- Release Date: 16/08/22 09:45
- Summary: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
- Price Sensitive: Yes
- Download Document 155.53KB
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 133255 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 09.47am 28/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |
Day chart unavailable